Brief: Replicel life sciences announces restructuring
06/04/2016 13:00
April 6 (Reuters) - Replicel Life Sciences Inc RP.V
* Replicel life sciences announces restructuring, cost
reductions and closing of private placement
* Board of directors has authorized a plan to downsize all
non-critical programs and staff
* Closed non-brokered private placement of 1.9 million
shares at a price of $0.20 per share
Source text for Eikon: ID:nCCN4txgd7
Further company coverage: RP.V
Recent news on Replicel Life Sciences
See all newsBrief: Replicel Life Sciences Announces Reinstatement Of Trading & Conditional Acceptance For Proposed Transaction
Brief: Replicel Life Sciences Says Replicel Announces A Letter Of Intent For Asset Purchase Agreement
Brief: Replicel Announces Binding Term Sheet For Strategic Investment And U.S. Partnership
Brief: Replicel Announces Its Incoming Board Of Directors
Brief: RepliCel Life Sciences Retains Dermatology Sales And Marketing Executive To Guide Global Commercial Strategy For Automated Dermal Injector